In other trial news, genetic medicine house PYC Therapeutics (ASX:PYC) has been given the go-ahead to start a local trial of ...
Shares climb after the company lifts its interim dividend by 34.5 per cent and announces a 184 per cent surge in net profit ...
The US Food and Drug Administration banned the use of powdered surgical gloves in December 2016, which was a boost to higher-end players such as Ansell. In addition, the trends toward higher price ...